Geller Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,500
Closed -$553K 91
2020
Q2
$553K Hold
12,500
0.17% 27
2020
Q1
$449K Hold
12,500
0.13% 25
2019
Q4
$886K Hold
12,500
0.27% 17
2019
Q3
$935K Hold
12,500
0.34% 13
2019
Q2
$1.01M Buy
12,500
+7,051
+129% +$496K 0.39% 11
2019
Q1
$364K Hold
5,449
0.15% 20
2018
Q4
$406K Hold
5,449
0.19% 20
2018
Q3
$502K Sell
5,449
-17,251
-76% -$1.64M 0.3% 18
2018
Q2
$2.23M Hold
22,700
0.97% 6
2018
Q1
$2.53M Hold
22,700
1.23% 5
2017
Q4
$2.33M Hold
22,700
1.18% 5
2017
Q3
$2.14M Hold
22,700
1.05% 5
2017
Q2
$1.77M Sell
22,700
-1,500
-6% -$113K 0.9% 5
2017
Q1
$1.94M Hold
24,200
1.05% 6
2016
Q4
$1.91M Sell
24,200
-1,155
-5% -$89.7K 1.13% 6
2016
Q3
$1.98M Sell
25,355
-2,500
-9% -$181K 1.13% 6
2016
Q2
$1.91M Hold
27,855
1.1% 6
2016
Q1
$1.99M Hold
27,855
1.19% 6
2015
Q4
$1.73M Sell
27,855
-3,750
-12% -$229K 1.03% 7
2015
Q3
$1.79M Hold
31,605
1.14% 7
2015
Q2
$1.7M Hold
31,605
0.99% 8
2015
Q1
$1.5M Hold
31,605
0.87% 8
2014
Q4
$1.37M Sell
31,605
-2,000
-6% -$81.7K 0.79% 10
2014
Q3
$1.16M Hold
33,605
0.65% 13
2014
Q2
$1.23M Hold
33,605
0.82% 9
2014
Q1
$1.13M Sell
33,605
-3,250
-9% -$107K 0.75% 10
2013
Q4
$1.25M Sell
36,855
-1,600
-4% -$55.4K 0.84% 9
2013
Q3
$1.23M Sell
38,455
-610
-2% -$16.2K 0.92% 9
2013
Q2
$882K Buy
+39,065
New +$846K 0.75% 11

Other funds holding CMD

Geller Advisors's CMD Position: Q3 2020 in Review

Geller Advisors sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 12,500 shares — an estimated $553K sold.

Geller Advisors first reported a position in CMD in Q2 2013 and held it in 29 quarters. The position peaked at $2.53M in Q1 2018. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

  • Geller Advisors reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
  • Geller Advisors sold 12,500 Cantel Medical Corporation shares in Q3 2020, an estimated $553K.
  • Geller Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 29 quarters.
  • Geller Advisors's Cantel Medical Corporation position peaked at $2.53M in Q1 2018.
  • 196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Geller Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.